The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116827979 11682797 9 F 2015 20160711 20151029 20160715 EXP US-ALEXION PHARMACEUTICALS INC-A201504118 ALEXION 0.00 F Y 0.00000 20160715 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116827979 11682797 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) UNK Y T2-AD3636B01 125166 CONCENTRATE FOR SOLUTION FOR INFUSION
116827979 11682797 2 SS SOLIRIS ECULIZUMAB 1 UNK Y T2-AD4285B01 125166 CONCENTRATE FOR SOLUTION FOR INFUSION
116827979 11682797 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, UNK Y T2-AE0884B01R 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION
116827979 11682797 4 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, QW Y 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
116827979 11682797 5 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, Q2W Y 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
116827979 11682797 6 C DIPRIVAN PROPOFOL 1 Unknown 0
116827979 11682797 7 C LEVOPHED NOREPINEPHRINE BITARTRATE 1 Unknown UNK 0
116827979 11682797 8 C EPOGEN ERYTHROPOIETIN 1 Unknown UNK UNK, QW 0 /wk
116827979 11682797 9 C RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) UNK, QW/EVERY FRIDAY 0 /wk
116827979 11682797 10 C PREDNISONE. PREDNISONE 1 Unknown UNK, TAPPERING OFF 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116827979 11682797 1 Haemolytic uraemic syndrome
116827979 11682797 6 Product used for unknown indication
116827979 11682797 7 Product used for unknown indication
116827979 11682797 8 Product used for unknown indication
116827979 11682797 9 Product used for unknown indication
116827979 11682797 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
116827979 11682797 OT
116827979 11682797 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116827979 11682797 Acute kidney injury
116827979 11682797 Altered state of consciousness
116827979 11682797 Anger
116827979 11682797 Blood creatinine abnormal
116827979 11682797 Blood lactate dehydrogenase increased
116827979 11682797 Cerebrovascular accident
116827979 11682797 Encephalopathy
116827979 11682797 General physical health deterioration
116827979 11682797 Haematocrit decreased
116827979 11682797 Haemoglobin decreased
116827979 11682797 Headache
116827979 11682797 Hemiparesis
116827979 11682797 Hemiplegia
116827979 11682797 Hypoaesthesia
116827979 11682797 Memory impairment
116827979 11682797 Mobility decreased
116827979 11682797 Paraesthesia
116827979 11682797 Posterior reversible encephalopathy syndrome
116827979 11682797 Renal impairment
116827979 11682797 Respiratory failure
116827979 11682797 Thrombocytopenic purpura
116827979 11682797 Urine output increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116827979 11682797 5 20151123 0